These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30734695)

  • 21. Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger.
    Arzika AM; Maliki R; Boubacar N; Kane S; Cook CA; Lebas E; Lin Y; O'Brien KS; Austin A; Keenan JD; Lietman TM; Oldenburg CE; For The Mordor Study Group
    Am J Trop Med Hyg; 2020 Sep; 103(3):1315-1318. PubMed ID: 32067628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a prospect for mass drug administration of azithromycin to reduce child mortality in sub-Saharan Africa?
    Amouzou A
    BMJ Evid Based Med; 2019 Oct; 24(5):e7-e8. PubMed ID: 30606733
    [No Abstract]   [Full Text] [Related]  

  • 23. Childhood mortality in a cohort treated with mass azithromycin for trachoma.
    Keenan JD; Ayele B; Gebre T; Zerihun M; Zhou Z; House JI; Gaynor BD; Porco TC; Emerson PM; Lietman TM
    Clin Infect Dis; 2011 Apr; 52(7):883-8. PubMed ID: 21427395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial.
    Adubra L; Alber D; Ashorn P; Ashorn U; Cheung YB; Cloutman-Green E; Diallo F; Ducker C; Elovainio R; Fan YM; Gates L; Gruffudd G; Haapaniemi T; Haidara F; Hallamaa L; Ihamuotila R; Klein N; Luoma J; Martell O; Sow S; Vehmasto T;
    Trials; 2023 Jan; 24(1):5. PubMed ID: 36597115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial.
    Arzika AM; Maliki R; Ali MM; Alio MK; Abdou A; Cotter SY; Varnado NE; Lebas E; Cook C; Oldenburg CE; O'Brien KS; Callahan EK; Bailey RL; West SK; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2021 Dec; 4(12):e2139351. PubMed ID: 34967883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR).
    O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM;
    BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azithromycin to prevent deaths in children.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2018 Jun; 18(6):583. PubMed ID: 29856346
    [No Abstract]   [Full Text] [Related]  

  • 28. Mass Drug Administration of Azithromycin to Reduce Child Mortality: Only for High-Mortality Settings?
    Tickell KD; Deichsel EL; Walson JL
    Am J Trop Med Hyg; 2020 Sep; 103(3):1274-1275. PubMed ID: 30734698
    [No Abstract]   [Full Text] [Related]  

  • 29. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial.
    Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD;
    PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial.
    Sié A; Bountogo M; Zakane A; Compaoré G; Ouedraogo T; Lebas E; Nyatigo F; Hu H; Brogdon J; Arnold BF; Lietman TM; Oldenburg CE
    Am J Trop Med Hyg; 2022 Dec; 107(6):1331-1336. PubMed ID: 36343592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial.
    Oldenburg CE; Amza A; Cooley G; Kadri B; Nassirou B; Arnold BF; Rosenthal PJ; O'Brien KS; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Martin DL
    Malar J; 2019 Dec; 18(1):389. PubMed ID: 31796025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial mass drug administration for child mortality reduction: Opportunities, concerns, and possible next steps.
    Bogoch II; Utzinger J; Lo NC; Andrews JR
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007315. PubMed ID: 31120903
    [No Abstract]   [Full Text] [Related]  

  • 33. Mass administration of azithromycin reduces childhood mortality in Niger.
    Murphy S; Datoo MS
    Arch Dis Child Educ Pract Ed; 2021 Oct; 106(5):320. PubMed ID: 32900778
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of azithromycin in infants under six months of age in Niger: A community randomized trial.
    Oldenburg CE; Arzika AM; Maliki R; Kane MS; Lebas E; Ray KJ; Cook C; Cotter SY; Zhou Z; West SK; Bailey R; Porco TC; Keenan JD; Lietman TM;
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006950. PubMed ID: 30419040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse Events and Clinic Visits following a Single Dose of Oral Azithromycin among Preschool Children: A Randomized Placebo-Controlled Trial.
    Sié A; Dah C; Bountogo M; Ouattara M; Nebie E; Coulibaly B; Brogdon JM; Godwin WW; Lebas E; Doan T; Arnold BF; Porco TC; Lietman TM; Oldenburg CE;
    Am J Trop Med Hyg; 2020 Dec; 104(3):1137-1141. PubMed ID: 33350370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Azithromycin during Routine Well-Infant Visits to Prevent Death.
    Sié A; Ouattara M; Bountogo M; Boudo V; Ouedraogo T; Compaoré G; Dah C; Bagagnan C; Lebas E; Hu H; Rice J; Porco TC; Arnold BF; Lietman TM; Oldenburg CE
    N Engl J Med; 2024 Jan; 390(3):221-229. PubMed ID: 38231623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution.
    Doan T; Hinterwirth A; Worden L; Arzika AM; Maliki R; Abdou A; Kane S; Zhong L; Cummings ME; Sakar S; Chen C; Cook C; Lebas E; Chow ED; Nachamkin I; Porco TC; Keenan JD; Lietman TM
    Nat Med; 2019 Sep; 25(9):1370-1376. PubMed ID: 31406349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
    Chao DL; Arzika AM; Abdou A; Maliki R; Karamba A; Galo N; Beidi D; Harouna N; Abarchi M; Root E; Mishra A; Lebas E; Arnold BF; Oldenburg CE; Keenan JD; Lietman TM; O'Brien KS
    JAMA Netw Open; 2023 Dec; 6(12):e2346840. PubMed ID: 38100110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
    Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B
    N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.